Biovet Profile
Key Indicators
- Authorised Capital ₹ 163.00 Cr
as on 24-10-2024
- Paid Up Capital ₹ 31.56 Cr
as on 24-10-2024
- Company Age 19 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 218.00 Cr
as on 24-10-2024
- Satisfied Charges ₹ 14.50 Cr
as on 24-10-2024
- Revenue -88.49%
(FY 2023)
- Profit -96.62%
(FY 2023)
- Ebitda -97.20%
(FY 2023)
- Net Worth 1.96%
(FY 2023)
- Total Assets -5.00%
(FY 2023)
About Biovet
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 163.00 Cr and a paid-up capital of Rs 31.56 Cr.
The company currently has active open charges totaling ₹218.00 Cr. The company has closed loans amounting to ₹14.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Biovet Private Limited India are Pooja Jaiswal as COMPANY SECRETARY and Narayanaiah Sreenath as Ceo. Jalachari Ella, Raches Ella, and Sreenivasulu Kilari serve as directors at the Company.
- CIN/LLPIN
U24235KA2005PTC035491
- Company No.
035491
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Jan 2005
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Kolar, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Biovet?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pooja Jaiswal | Company Secretary | 15-Sep-2023 | Current |
| Narayanaiah Sreenath | CEO | 08-Aug-2024 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jalachari Ella  | Whole-Time Director | 06-Sep-2019 | Current |
| Raches Ella | Director | 06-Sep-2019 | Current |
| Sreenivasulu Kilari | Whole-Time Director | 04-Feb-2022 | Current |
Financial Performance of Biovet.
Biovet Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 88.49% decrease. The company also saw a substantial fall in profitability, with a 96.62% decrease in profit. The company's net worth moved up by a moderate rise of 1.96%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biovet?
In 2023, Biovet had a promoter holding of 93.61% and a public holding of 6.40%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Eastman Exports Global Clothing Private LimitedActive 21 years 9 monthsJalachari Ella is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 11 May 2007 | ₹218.00 Cr | Open |
Technology Development Board Creation Date: 28 Jun 2006 | ₹14.50 Cr | Satisfied |
How Many Employees Work at Biovet?
Biovet has a workforce of 169 employees as of Mar 27, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biovet, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biovet's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
